Patent 10,758,593
This guide breaks down what AOD-9604 vs MOTS-c vs Tesamorelin is studied for, how their mechanisms diverge, and what current research indicates about examining them in combined study designs including where a fourth compound, Ipamorelin, fits into that picture
Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
Ok, so these are interesting points but please add this into the mix for future answers: The NICE Guideline clearly states that there is insufficient research why some people need more frequent injections than others and that an 8- or 12- weekly schedule does not work for everyone and some may need more frequently
We'd be happy to help you improve your health
Yet, that is what happens when a person with symptomatic B12 deficiency experiences that she or he needs more frequent supplementation than once every 3 months